ArticleCureus2025
Aggressive Follicular Lymphoma of the Breast: An Unusual Suspect.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary lymphoma of the breast: A case report.Radiology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular lymphoma (FL) of the breast represents an uncommon subtype of breast lymphoma, an unusual type of non-Hodgkin lymphoma (NHL). It typically presents as a secondary disease, meaning it is a manifestation of systemic lymphoma involving the breast rather than a primary breast origin. While screening efforts and outcomes of patients with breast cancer have risen dramatically in the last few decades, the same cannot be said of breast lymphoma. This can be partly due to the rarity of the condition and also due to the difficulty in diagnosing it. The diagnosis can often be masked by other conditions, such as benign breast masses or more common breast malignancies, such as carcinoma. This can lead to delays in diagnosis and disease progression. We describe a case of a patient who was diagnosed with aggressive FL of the breast. Despite the usual indolent nature of the disease, the patient's complicated medical comorbidities, including coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), and diabetes, resulted in challenges in treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.